UK markets closed
NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.82 -0.81 (-0.98%) GOLD FUTURES
2,308.00 -49.70 (-2.11%) DOW
38,071.18 -314.91 (-0.82%) Bitcoin GBP
50,119.69 -539.11 (-1.06%)
MRNA Jan 2025 125.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:28PM EDT. Market open.
| Previous close | 16.06 |
| Open | 15.56 |
| Bid | 15.30 |
| Ask | 16.25 |
| Strike | 125.00 |
| Expiry date | 2025-01-17 |
| Day's range | 15.56 - 16.06 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.52k |
ZacksThese 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Simply Wall St.We Think Shareholders May Want To Consider A Review Of Moderna, Inc.'s (NASDAQ:MRNA) CEO Compensation Package
Key Insights Moderna to hold its Annual General Meeting on 6th of May CEO Stephane Bancel's total compensation includes...
BenzingamRNA Is Promising A Breakthrough In Fighting Cancer
When it comes to cancer, there’s innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during the COVID-19 era as it allowed pharmaceutical companies like Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) to develop their groundbreaking vaccines in record time. By the looks of it, this was only the beginning of the healthcare revolution that mRNA triggered. Mainz Biomed N.V. (NASDAQ: MYNZ) to revolutionize c
© 2024 Yahoo. All rights reserved.